Berengere Ouine
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Uracil processing by SMUG1 in the absence of UNG triggers homologous recombination and selectively kills BRCA1/2-deficient tumors.
Journal: Molecular cell
Published: March 22, 2024
Proliferation Genes Repressed by TGF-β Are Downstream of Slug/Snail2 in Normal Bronchial Epithelial Progenitors and Are Deregulated in COPD.
Journal: Stem cell reviews and reports
Published: January 13, 2021
PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?
Journal: Clinics and research in hepatology and gastroenterology
Published: June 24, 2020
Analytical Platforms 1: Use of Cultured Cells and Fluorescent Read-Out Coupled to NormaCurve Normalization in RPPA.
Journal: Advances in experimental medicine and biology
Published: December 11, 2019
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies.
Journal: Scientific reports
Published: September 18, 2019
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.
Journal: Theranostics
Published: April 29, 2019
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma.
Journal: Cancers
Published: March 13, 2019
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
Journal: Gastroenterology
Published: February 06, 2019
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
Journal: International journal of cancer
Published: September 19, 2018
Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.
Journal: British journal of cancer
Published: June 15, 2018
Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.
Journal: British journal of cancer
Published: June 09, 2017
Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition.
Journal: Oncotarget
Published: April 27, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026